AI assistant
Dechra Pharmaceuticals PLC — Earnings Release 2019
Oct 18, 2019
4797_agm-r_2019-10-18_bf3e9177-f145-4736-a176-ad7d47f549e3.html
Earnings Release
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3070Q
Dechra Pharmaceuticals PLC
18 October 2019
Friday, 18 October 2019
Dechra® Pharmaceuticals PLC
(Dechra, Group, Company)
AGM Trading update
The Board of Dechra issues the following update prior to the Annual General Meeting (AGM) which will take place at the Company's offices at 6 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA at 1.00 pm today, Friday 18 October 2019.
The Board remains confident about the Company's prospects for the current financial year. Work continues to resolve the supply issues previously highlighted with many of these having now been mitigated.
No other new trading updates are to be made at the AGM today.
Dechra will announce its interim results for the six month period to 31 December 2019 on 24 February 2020.
| Enquiries: | |
| Dechra Pharmaceuticals PLC | |
| Ian Page, Chief Executive Officer | Office: +44 (0) 1606 814 730 |
| Paul Sandland, Acting Chief Financial Officer e-mail: [email protected] |
Office: +44 (0) 1606 814 730 |
| TooleyStreet Communications Ltd | |
| Fiona Tooley, Director e-mail: [email protected] |
Mobile: +44 (0) 7785 703 523 Office: +44 (0) 121 309 0099 |
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and relates products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.
For more information, please visit: www.dechra.com
Stock Code: Full Listing (Pharmaceuticals): DPH
LEI: 213800J4UVB5OWG8VX82
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
Forward Looking Statement
This document may contain certain forward-looking statements. The forward-looking statements reflect the knowledge and information available to the Company during the preparation and up to the publication of this document. By their very nature, these statements depend upon circumstances and relate to events that may occur in the future thereby involve a degree of uncertainty. Therefore, nothing in this document should be construed as a profit forecast by the Company.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
AGMLLFVDIVLDLIA